 | Up a level |
Martinelli, G.; Ryan, G.; Seymour, J. F.; Nassi, L.; Steffanoni, S.; Alietti, A.; Calabrese, L.; Pruneri, G.; Santoro, L.; Kuper-Hommel, M.; Tsang, R.; Zinzani, P. L.; Taghian, A.; Zucca, E.; Cavalli, F. (2009). Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Annals of oncology, 20(12), pp. 1993-1999. Oxford University Press 10.1093/annonc/mdp238
Ryan, G.; Martinelli, G.; Kuper-Hommel, M.; Tsang, R.; Pruneri, G.; Yuen, K.; Roos, D.; Lennard, A.; Devizzi, L.; Crabb, S.; Hossfeld, D.; Pratt, G.; Dell'Olio, M.; Choo, S. P.; Bociek, R. G.; Radford, J.; Lade, S.; Gianni, A. M.; Zucca, E.; Cavalli, F.; ... (2007). Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Annals of oncology, 19(2), pp. 233-241. Oxford University Press 10.1093/annonc/mdm471
Ferreri, A. J. M.; Blay, J.-Y.; Reni, M.; Pasini, F.; Gubkin, A.; Tirelli, U.; Calderoni, A.; Zucca, E.; Cortelazzo, S.; Chassagne, C.; Tinguely, M.; Borisch, B.; Berger, F.; Ponzoni, M.; Cavalli, F. (2002). Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Annals of oncology, 13(4), pp. 531-538. Oxford University Press 10.1093/annonc/mdf080
Roth, A. D.; Maibach, R.; Martinelli, G.; Fazio, N.; Aapro, M. S.; Pagani, O.; Morant, R.; Borner, M. M.; Herrmann, R.; Honegger, H.; Cavalli, F.; Alberto, P.; Castiglione, M.; Goldhirsch, A. (2000). Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma. Annals of oncology, 11(3), pp. 301-306. Oxford University Press 10.1023/A:1008342013224
Pagani, O.; Sessa, C.; Martinelli, G.; Cerny, Thomas; De Jong, J.; Goldhirsch, A.; Zimatore, M.; Cavalli, F. (1997). Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer. Annals of oncology, 8(7), pp. 655-661. Oxford University Press 10.1023/A:1008211629858
Goldhirsch, A.; Gelber, R. D.; Castiglione, M.; O'Neill, A.; Thürlimann, B.; Rudenstam, C.-M; Lindtner, J.; Collins, J.; Forbes, J.; Crivellari, D.; Coates, A.; Cavalli, F.; Simoncini, E.; Fey, M. F.; Pagani, O.; Price, K.; Senn, H.-J. (1997). Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology, 8(8), pp. 751-756. Oxford University Press 10.1023/A:1008220301866
Thürlimann, B.; Beretta, K.; Bacchi, M.; Castiglione-Gertsch, M.; Goldhirsch, A.; Jungi, W. F.; Cavalli, F.; Senn, H.-J.; Fey, M.; Löhnert, T. (1996). First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Annals of oncology, 7(5), pp. 471-479. Oxford University Press 10.1093/oxfordjournals.annonc.a010635
Davies, A. J.; Zucca, E.; Ceriani, L.; Kryachok, I.; Ciccone, G.; Botto, B.; Balzarotti, M.; Tucci, A.; Rusconi, C.; Usai, S. V.; Pennese, E.; Arcaini, L.; Dabrowska‐Iwanicka, A.; Ferreri, A. J. M.; Merli, F.; Zhao, W.; Hodgson, D.; Rigacci, L.; Cellini, C.; Stelitano, C.; ... (2023). A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY. Hematological oncology, 41(S2), pp. 48-50. Wiley 10.1002/hon.3163_19
